Dr. Lisa N. Boggio, MD

Dr. Boggio practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Boggio's NPI, 1336116151, was assigned on March 1, 2006. Dr. Boggio graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993. Dr. Boggio holds Illinois license 036091827.

Dr. Boggio's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Boggio's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Boggio is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Boggio to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boggio practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Boggio's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Boggio is board certified in hematology by the American Board of Internal Medicine. Dr. Boggio is licensed in Illinois.

Dmand AI lists chronic anemia and deep vein thrombosis (DVT) among the conditions Dr. Boggio treats.

CMS data shows 65 Medicare services from Dr. Boggio across 3 procedure codes in 2024, all of them office visits, for 63 Medicare patients. Medicare paid $7,178 for them. Every service was in an office.

CMS counts 63 Medicare patients who saw Dr. Boggio in 2024. The largest group is 75 to 84, with 22 patients. 67% of them have high blood pressure, and 63% have high cholesterol. 33% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boggio's median patient age at 46, with 65% women.

In 2024, Dr. Boggio wrote 222 Medicare Part D claims for 42 patients. 68% of them were for generic drugs. CMS names the drug for 162 of them, across 8 drugs with 11 or more claims each, at $42,447 in total drug cost. In 2023, CMS named 189 claims across 10 drugs.

Dr. Boggio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boggio as offering telehealth.

Dmand AI links 45 papers to Dr. Boggio, published from 2009 to 2024. 2017 was the busiest year, with 5. The most frequent topics are Hemophilia A, Factor VIII and Hemorrhage. Dr. Boggio has published most often in Haemophilia. Dr. Boggio's most frequent co-authors are Doris Voy Kan Quon, MD, Tyler Wayne Buckner, MD and Ralph A. Gruppo, MD.

Dmand AI links Dr. Boggio to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Hemophilia A, Hemophilia B and Coagulation Protein Disorders.

CMS Open Payments shows 504 general payments to Dr. Boggio from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Novo Nordisk Inc paid the most, $85,195. It also lists 3 research payments totaling $4,760 from 2020 to 2022.

Dmand AI lists 1 award for Dr. Boggio, most recently CMS Stage 1 EHR in 2013.

Dr. Boggio graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993.

Dr. Boggio is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.